Drugs / fenpiverinium
fenpiverinium
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05607641 | Jul 2021 → May 2022 | — | Darnitsa Pharmaceutical Company | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fenpiverinium | “Neospastil (ketorolac tromethamine / pitofenone hydrochloride / fenpiverinium bromide fixed-dose combination) in a form of solution for injections and film-coated tablets has...” NCT05607641 ↗ |
| Known as | Bromure de fenpiverinium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Known as | Bromuro de fenpiverinio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Known as | Fenpipramide bromomethylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Known as | FENPIVERINIUM BROMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Known as | Fenpiverinium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Known as | Fenpiverinium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1884833 ↗ |
| Modality | Small molecule | — CHEMBL1884833 ↗ |
| Route | Oral | “Study treatment was initiated with parenteral form of study drug (first 24 hours) and then switched to oral formulation.” NCT05607641 ↗ |
| Route | Other | “Study treatment was initiated with parenteral form of study drug (first 24 hours) and then switched to oral formulation.” NCT05607641 ↗ |